排序方式： 共有29条查询结果，搜索用时 0 毫秒
1.
Enooku K Tateishi R Kanai F Kondo Y Masuzaki R Goto T Shiina S Yoshida H Omata M Koike K 《Journal of gastroenterology》2012,47(1):71-78
Background
We evaluated the usefulness of tumor marker doubling time (DT) as an efficacy indicator of a molecular targeted anticancer agent. 相似文献2.
Perihepatic lymph node enlargement observed at a general health examination: A cross‐sectional study
3.
Slight elevation of high‐sensitivity C‐reactive protein to predict recurrence and survival in patients with early stage hepatitis C‐related hepatocellular carcinoma 
下载免费PDF全文
下载免费PDF全文 4.
5.
Nakatsuka Takuma Nakagawa Hayato Hayata Yuki Wake Taijiro Yamada Tomoharu Nishibatake Kinoshita Mizuki Nakagomi Ryo Sato Masaya Minami Tatsuya Uchino Koji Enooku Kenichiro Kudo Yotaro Tanaka Yasuo Kishikawa Takahiro Otsuka Motoyuki Tateishi Ryosuke Koike Kazuhiko 《Journal of gastroenterology》2021,56(5):456-469
Journal of Gastroenterology - Liquid biopsies, particularly those involving circulating tumor DNA (ctDNA), are rapidly emerging as a non-invasive alternative to tumor biopsies. However, clinical... 相似文献
6.
7.
Tumor markers are more useful in patients undergoing surveillance for hepatocellular carcinoma with unreliable results by ultrasonography 下载免费PDF全文
下载免费PDF全文 8.
9.
Enooku Kenichiro Kondo Mayuko Fujiwara Naoto Sasako Takayoshi Shibahara Junji Kado Akira Okushin Kazuya Fujinaga Hidetaka Tsutsumi Takeya Nakagomi Ryo Minami Tatsuya Sato Masaya Nakagawa Hayato Kondo Yuji Asaoka Yoshinari Tateishi Ryosuke Ueki Kohjiro Ikeda Hitoshi Yoshida Haruhiko Moriya Kyoji Yotsuyanagi Hiroshi Kadowaki Takashi Fukayama Masashi Koike Kazuhiko 《Journal of gastroenterology》2018,53(12):1261-1275
Journal of Gastroenterology - Nonalcoholic fatty liver disease (NAFLD) is a risk factor for type 2 diabetes. Our aim was to investigate the relationship between NAFLD and impaired glucose... 相似文献
10.
Kazuya Okushin Takeya Tsutsumi Kazuhiko Ikeuchi Akira Kado Kenichiro Enooku Hidetaka Fujinaga Kyoji Moriya Hiroshi Yotsuyanagi Kazuhiko Koike 《World journal of gastroenterology : WJG》2018,24(32):3617-3625
Both Helicobacter pylori(H. pylori) infection and liver diseases, including nonalcoholic fatty liver disease(NAFLD), viral hepatitis, and hepatocellular carcinoma(HCC), have high prevalences worldwide, and the relationship between H. pylori infection and liver disease has been discussed for many years. Although positive correlations between H. pylori and NAFLD have been identified in some clinical and experimental studies, nega-tive correlations have also been obtained in high-quality clinical studies. Associations between H. pylori and the pathogenesis of chronic viral hepatitis, mainly disease progression with fibrosis, have also been suggested in some clinical studies. Concerning HCC, a possible role for H. pylori in hepatocarcinogenesis has been identified since H. pylori genes have frequently been detected in resected HCC specimens. However, no study hasrevealed the direct involvement of H. pylori in promoting the development of HCC. Although findings regarding the correlations between H. pylori and liver disease pathogenesis have been accumulating, the existing data do not completely lead to an unequivocal conclusion. Further high-quality clinical and experimental analyses are necessary to evaluate the efficacy of H. pylori eradication in ameliorating the histopathological changes observed in each liver disease. 相似文献